Ovarian function was assessed every 6 months for 2 years since enrollment on the basis of follicular-stimulating hormone levels and vaginal
Endometrial hyperplasia (thickening of the uterine lining): After menopause, you may have too much Non-gynaecological causes including trauma or a bleeding disorder
PURPOSE To determine the updated long-term outcomes of the Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal Bleeding After Chemotherapy (ASTRRA) trial
Related Terms: Purpose: To determine the updated long-term outcomes of the Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal Bleeding After Chemotherapy (ASTRRA) trial
Premenopausal women — tamoxifen has been associated with reduced bone density in premenopausal women, fluid retention, vaginal bleeding, vaginal discharge, fatigue, and skin rash
Uncommon but serious adverse effects include Conclusion: In premenopausal BC patients treated with tamoxifen, abnormal uterine bleeding, increased endometrial thickness, and chemotherapy for BC were associated with the occurrence of endometrial cancer
I just kept my bcn informed and for a while just kept an eye on it, then was sent for a couple of scans to check for thickened womb lining
Several strategies are used to treat hormone-sensitive breast cancer: Blocking ovarian function: Because the ovaries are the main source of estrogen in premenopausal women, estrogen levels in these women can be reduced by eliminating or suppressing ovarian function
Objective: We describe an unusual histological finding in a woman with postmenopausal bleeding who was being treated with tamoxifen for breast cancer
Raloxifene is used mostly to prevent and treat osteoporosis (very weak bones) in post-menopausal women
irregular bleeding
vaginal bleeding (and not on tamoxifen): suggested upper limit of normal is <5 mm 5